South Korea Palliative Care Market

ID: MRFR/MED/47689-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026
South Korea Palliative Care Market Research Report By Type (Hospital Inpatient Care, Hospice Inpatient Care, Nursing Homes, Residential Facility Care, Homecare, Private Residence Care), By End-User (Long Term Care Centers & Rehabilitation Centers, Hospitals & Clinics, Palliative Care Centers, Home Care Settings) and By Application (Cardiac Disease, Congestive Heart Failure, Cancer, Chronic Obstructive Pulmonary Disease (COPD), Kidney Failure, Alzheimer’s Disease, Parkinson’s Disease, Amyotrophic Lateral Sclerosis (ALS)) -Forecast to 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South Korea Palliative Care Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)7.44%
2024 Market Size$ 109.4 Million
2025 Market Size$ 117.54 Million
2035 Market Size$ 241 Million

Key Players

VITAS Healthcare
Amedisys Inc
LHC Group
Brookdale Senior Living
Kindred Healthcare
Curo Health Services
Opportunities
  • Government Initiatives and Funding
  • Aging Population and Chronic Illnesses
  • Technological Advancements in Healthcare
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Type (USD Million)
      1. 4.1.1 Hospital Inpatient Care
      2. 4.1.2 Hospice Inpatient Care
      3. 4.1.3 Nursing Homes
      4. 4.1.4 Residential Facility Care
      5. 4.1.5 Homecare
      6. 4.1.6 Private Residence Care
    2. 4.2 Healthcare, BY End-User (USD Million)
      1. 4.2.1 Long Term Care Centers & Rehabilitation Centers
      2. 4.2.2 Hospitals & Clinics
      3. 4.2.3 Palliative Care Centers
      4. 4.2.4 Home Care Settings
    3. 4.3 Healthcare, BY Application (USD Million)
      1. 4.3.1 Cardiac Disease
      2. 4.3.2 Congestive Heart Failure
      3. 4.3.3 Cancer
      4. 4.3.4 Chronic Obstructive Pulmonary Disease (COPD)
      5. 4.3.5 Kidney Failure
      6. 4.3.6 Alzheimer’s Disease
      7. 4.3.7 Parkinson’s Disease
      8. 4.3.8 Amyotrophic Lateral Sclerosis (ALS)
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 VITAS Healthcare (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Amedisys Inc (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 LHC Group (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Brookdale Senior Living (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Kindred Healthcare (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Curo Health Services (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Compassus (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Palliative Care Center (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH KOREA MARKET ANALYSIS BY TYPE
    3. 6.3 SOUTH KOREA MARKET ANALYSIS BY END-USER
    4. 6.4 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    5. 6.5 KEY BUYING CRITERIA OF HEALTHCARE
    6. 6.6 RESEARCH PROCESS OF MRFR
    7. 6.7 DRO ANALYSIS OF HEALTHCARE
    8. 6.8 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    9. 6.9 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    10. 6.10 SUPPLY / VALUE CHAIN: HEALTHCARE
    11. 6.11 HEALTHCARE, BY TYPE, 2024 (% SHARE)
    12. 6.12 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Million)
    13. 6.13 HEALTHCARE, BY END-USER, 2024 (% SHARE)
    14. 6.14 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Million)
    15. 6.15 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    16. 6.16 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
    17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY END-USER, 2025-2035 (USD Million)
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

South Korea South Korea Palliative Care Market Segmentation

South Korea Palliative Care Market By Type (USD Million, 2025-2035)

  • Hospital Inpatient Care
  • Hospice Inpatient Care
  • Nursing Homes
  • Residential Facility Care
  • Homecare
  • Private Residence Care

South Korea Palliative Care Market By End-User (USD Million, 2025-2035)

  • Long Term Care Centers & Rehabilitation Centers
  • Hospitals & Clinics
  • Palliative Care Centers
  • Home Care Settings

South Korea Palliative Care Market By Application (USD Million, 2025-2035)

  • Cardiac Disease
  • Congestive Heart Failure
  • Cancer
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Kidney Failure
  • Alzheimer’s Disease
  • Parkinson’s Disease
  • Amyotrophic Lateral Sclerosis (ALS)